GW823093C For The Treatment Of Type 2 Diabetes Mellitus

Clinical trial NCT00370942 · TERMINATED

Trial details

NCT number: NCT00370942
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2006-04-01
Primary completion: 2006-11-01
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.